EPIQ Capital Group, LLC Insider Profile
11 Followers
EPIQ Capital Group, LLC, IA/Managing Member of 10% Owne at IRulya Therapeutics, holds 1.34M shares in Lucira Health (Ticker: LHDXQ), holds 8.34M shares in Applied Molecular Transport (Ticker: AMTI), holds 2.86M shares in IRulya Therapeutics (Ticker: IRLA).
EPIQ Capital Group, LLC's Trading History
| LHDXQLucira Health | Dec 16, 2022 | ― | Uninformative Sell | ― | $13.36K | |
| AMTIApplied Molecular Transport | May 16, 2022 | ― | Informative Buy | 249.75K | $2.19M | |
| IRLAIRulya Therapeutics | Jun 15, 2020 | IA/Managing Member of 10% Owne | Informative Buy | 400.02K | $106.89M |
You May Also Like
EPIQ Capital Group, LLC insider profile FAQ
What is the percentage of profitable transactions made by EPIQ Capital Group, LLC?
The percentage of profitable transactions made by EPIQ Capital Group, LLC is 50%.
What is the average return per transaction made by EPIQ Capital Group, LLC?
The average return per transaction made by EPIQ Capital Group, LLC is -11.70%.
What stocks does EPIQ Capital Group, LLC hold?
EPIQ Capital Group, LLC holds: IRLA, AMTI, LHDXQ stocks.
What was EPIQ Capital Group, LLC's most profitable transaction?
EPIQ Capital Group, LLC’s most profitable transaction was an Informative Buy of AMTI stock on June 11, 2020. The return on the trade was 88.80%.
What is EPIQ Capital Group, LLC's role in IRulya Therapeutics?
EPIQ Capital Group, LLC's role in IRulya Therapeutics is IA/Managing Member of 10% Owne.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
